Nestle's two products have been registered as formula food for special medical use in China
date：2020-01-20
browse：（1429）
Keyword： Nestle, FSMP ,China
On January 17, Nestle held a brand press conference of “Tai min shu, Ai er shu” in Guangzhou, congratulating two milk protein deep hydrolyzed formula infant formula for special medical use to obtain the registration license of formula food for special medical use in China. At the press conference, Gu xinxin, president of Nestle health Greater China, said that the company has been deeply insight into the needs and industry trends of allergic infants in China.
Both products have been improved in strict accordance with the relevant requirements of China national standards, so that the formula more in line with the needs of China’s allergic babies, and has been recognized by the national registration.
Source: China Economic Com
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
